Biotech grants
Explore grants for biotech companies. This directory brings together funding for therapeutics, diagnostics, platform technologies, bioprocessing and translational research, from health research agencies, national innovation programs, disease foundations and industry partnerships.
Showing 1,009-1,032 of 2,745 grants
Limited Competition: The NHGRI Analysis, Visualization, and Informatics Lab-space (AnVIL)
NIH · United States
Funds one renewed operator for AnVIL, the cloud platform holding more than 5 petabytes of genomic data for reproducible research.
Childhood Asthma in Urban Settings Clinical Research Network
🇺🇸NIH · United States
Funds a clinical trials network testing asthma prevention and treatment ideas in economically disadvantaged, high-burden urban children.
Improved Drug Susceptibility Testing (DST) for Mycobacteria
NIH · United States
Funds faster drug-susceptibility tests for tuberculosis and related mycobacterial infections that skip slow culture-based methods.
NIDDK Disease Research and Translational Core Centers
🇺🇸NIH · United States
Funds shared core facilities and small pilot grants at institutions with an established research base in a named NIDDK disease area.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds further development and rigorous technical validation of a cancer research technology that has already cleared basic feasibility.
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research
NIH · United States
Funds early proof-of-concept work testing whether a new cancer research tool, assay, platform or instrument is technically feasible at all.
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2
🇺🇸NIH · United States
Funds single-cell research into how opioid use and HIV interact in brain tissue, building on the SCORCH consortium's first phase.
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management
NIH · United States
Funds the ongoing development, dissemination or upkeep of a cancer informatics tool that has already outgrown its prototype stage.
INCLUDE Project: Omics Phenotypes Related to Down Syndrome
NIH · United States
Funds access to genomic and multi-omics processing of Down syndrome biospecimens through NIH's INCLUDE Project, with no direct cash award.
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development
NIH · United States
Funds small-molecule drug candidates from a lab bench through Phase I testing, with NIH's own chemistry and toxicology experts on call.
Alzheimer's Drug-Development Program
🇺🇸NIH · United States
Funds early drug candidates for Alzheimer's disease, from lab bench through the first human safety trial.
NIAMS Clinical Trial Implementation Cooperative Agreement
NIH · United States
Funds a two-phase cooperative agreement to prepare for, then run, a clinical trial in arthritis, musculoskeletal or skin disease.
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics
NIH · United States
Funds better drug dosing and safer medicines for pregnant women, lactating women, infants, children and adolescents.
Cancer Mission: First-in-Human Trials for Rare Cancers
🇪🇺European Commission · European Union
Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.
Cancer Mission: Functional Genomics for New Treatments
🇪🇺European Commission · European Union
Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.
Clinical Research for Common Cancers
🇪🇺European Commission · European Union
Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.
Equitable Cancer Care Economics and Outcomes
🇪🇺European Commission · European Union
Funds three €5–7M projects that make cancer control more equitable, effective and cost-aware for patients and families.
Mission Soil and Cancer: Living Labs for Carcinogenic Contamination
🇪🇺European Commission · European Union
Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.
Pre-Commercial Procurement for Cancer Care
🇪🇺European Commission · European Union
Funds €8–10M procurer consortia to bring affordable cancer technologies, devices and medicines from tender to patient benefit.
Young Cancer Survivors Quality of Life Network
🇪🇺European Commission · European Union
Funds one €3M coordination action that helps cancer charities and funders improve quality of life for young survivors across Europe.
Horizon Bio-CCU: Carbon to Products
🇪🇺European Commission · European Union
Funds two €6M projects that use biotechnology to purify captured carbon and turn it into sustainable feedstock for industrial products.
Horizon Biotech for Complex Plastic Recycling
🇪🇺European Commission · European Union
Funds two €5M projects to use biotechnology to recycle complex plastics into high-value products at pilot scale across industrial value chains.
Horizon Circular Bio-Based Value Chains
🇪🇺European Commission · European Union
Funds €6M projects that turn bio-waste and secondary raw materials into safe, circular products, materials and value chains.
Horizon Health: Bio-printing for Regenerative Medicine
🇪🇺European Commission · European Union
Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.